Zynga gets “Sell” Rating by TheStreet; Bristol-Myers Reports Disappointing Trial Data on Experimental Cancer Drug Nivolumab

Follow this company

Companies Mentioned

05/16/2014 [ACCESSWIRE]

Bristol-Myers Squibb Company (NYSE: BMY) - For an in-depth report on Bristol-Myers Squibb Company follow: www.BullTrends.com/stockquote/BMY

Shares of Bristol-Myers Squibb Company closed down 6.12% on about 28.6 million shares traded. The stock was one of the biggest decliners on the NYSE. The drop came after the company reported disappointing clinical trial data for an experimental cancer treatment. Bristol-Myers revealed data from several early-stage clinical studies of its cancer drug nivolumab. Nivolumab hasn't yet been approved, but Bristol-Myers Squibb is getting ready to file for approval of the drug as a treatment for non-small cell lung cancer.

Zynga, Inc. (NASDAQ: ZNGA) - For an in-depth report on Zynga, Inc. follow: www.BullTrends.com/stockquote/ZNGA

Shares of ZNGA closed down 4.41% on about 42.2 million shares traded. The stock was one of the most active stocks on the NASDAQ. TheStreet Ratings team has reiterated its "sell" rating on the stock with a ratings score of D+. The team has said, “The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow."

Symantec Corporation (NASDAQ: SYMC) - For an in-depth report on Symantec Corporation follow: www.BullTrends.com/stockquote/SYMC

Symantec Corporation closed up 4.20% on about 15.4 million shares traded. The stock was one of the biggest gainers on the NASDAQ on Thursday. The company issued a revenue forecast that topped projections. The company has reported that sales in the fiscal first quarter will be $1.65 billion to $1.69 billion. Analysts, on average, are predicting revenue of $1.64 billion for the period that ends in June, according to data compiled by Bloomberg.

Liquid Holdings Group, Inc. (NASDAQ: LIQD) - For an in-depth report on Liquid Holdings Group, Inc. follow:  www.BullTrends.com/stockquote/LIQD

Shares of Liquid Holdings Group closed down 46.09% on nearly 4 million shares traded. The stock was one of the biggest decliners on the NASDAQ and hit a new yearly low of $1.20 during intra-day trading. The company priced a secondary offering of 32 million shares of common stock and also announced it will price the 32 million share public offer at $1.25 a share. Liquid granted the underwriters of the offering a 30-day option to buy an additional 4.8 million shares of common stock to cover over-allotments. 


Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures. 


Leave a comment...

Your Name